文献速递疼痛医学神经外科与老年麻醉

GABA能丘脑皮层环路介导糖尿病神经病理性疼痛的缓解

A GABAergic neuronal thalamocortical circuit mediates the relief of diabetic neuropathic pain.
PubMed 文献 · Br J Anaesth · 2025-07-31

该研究在链脲佐菌素诱导的雄性大鼠糖尿病神经病理性疼痛模型中,通过光遗传学和化学遗传学激活VPL GABA能神经元及其投射至S1FL的丘脑皮层环路,可缓解机械性异常性疼痛,揭示该环路介导镇痛效应并为镇痛药研发提供新思路。

要点

  • 激活VPL GABA能神经元可缓解DNP模型大鼠的机械性异常性疼痛。
  • VPL至S1FL的GABA能丘脑皮层环路介导镇痛效应。
  • 该环路为糖尿病神经病理性疼痛的镇痛治疗提供了新靶点。

核心结论

  • VPL GABA能神经元及其投射至S1FL的丘脑皮层环路介导抗伤害感受效应,可缓解糖尿病神经病理性疼痛。

研究设计与样本

  • 在雄性大鼠中构建链脲佐菌素诱导的糖尿病神经病理性疼痛模型,采用免疫荧光染色和von Frey测试评估VPL神经元活动。
  • 采用光遗传学、化学遗传学、病毒示踪和行为学测试研究VPL GABA能神经元及投射至S1FL的环路作用。

主要发现

  • 光遗传学激活VPL GABA能神经元缓解雄性DNP模型大鼠机械性异常性疼痛(F2,18=376.155,P<0.001)。
  • 化学遗传学激活VPL GABA能神经元缓解雄性DNP模型大鼠机械性异常性疼痛(F2,16=226.340,P<0.001)。
  • 光遗传学激活VPL至S1FL的GABA能丘脑皮层环路介导抗伤害感受效应(F2,20=303.807,P<0.001)。
  • 化学遗传学激活VPL至S1FL的GABA能丘脑皮层环路介导抗伤害感受效应(F2,15=62.008,P<0.001)。

临床怎么用

  • VPL GABA能神经元及VPL-S1FL丘脑皮层环路可作为糖尿病神经病理性疼痛的潜在镇痛靶点。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Diabetic neuropathic pain (DNP) is a severe and clinically common form of neuropathic pain. Ventral posterolateral nucleus (VPL) glutamatergic neurones are reportedly involved in the development of neuropathic pain. However, the roles and mechanism of VPL GABAergic neurones and neural circuits in DNP remain unclear. METHODS: After constructing a streptozotocin (STZ)-induced DNP model in male rats, we assessed VPL neuronal activity by immunofluorescence staining and von Frey test. Moreover, the roles of VPL GABAergic neurones and that projected to the forelimb primary somatosensory cortex (S1FL) were investigated using optogenetic and chemogenetic approaches, viral tracing, and behavioural tests. RESULTS: Optogenetic (F2,18=376.155, P<0.001) and chemogenetic (F2,16=226.340, P<0.001) activation of VPL GABAergic neurones relieved mechanical allodynia in male DNP model rats, which revealed that VPL GABAergic neurones mediated antinociceptive effects. We identified a GABAergic thalamocortical circuit in the VPL that projected to the S1FL and revealed that the thalamocortical circuit mediated antinociceptive effects (optogenetic: F2,20=303.807, P<0.001; chemogenetic: F2,15=62.008, P<0.001) in the context of DNP. CONCLUSIONS: These findings identify a GABAergic neuronal thalamocortical circuit associated with pain processing, reveal the mechanism of diabetic neuropathic pain pathogenesis and the role of thalamocortical pain circuits in analgesia, and provide new insights for the development of analgesics.

来源:Br J Anaesth,查看原文。版权归原作者所有。

引用

  1. Chen J, Yang L, Chen J, et al. A GABAergic neuronal thalamocortical circuit mediates the relief of diabetic neuropathic pain. Br J Anaesth. 2025. PMID: 40744795. doi:10.1016/j.bja.2025.05.049

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。